Measuring impact has been a central theme in the Health Insurance Fund’s approach from the onset.
Health Insurance Fund attaches great importance to making sure that its efforts add value for our beneficiaries in sub-Saharan Africa and to learning how to do better. Constantly evaluating and monitoring the impact of a program is a core element within all the programs. Systematic data collection, data management, reporting and analysis generates a wealth of information on the impact on both the demand (low-income people and patients) and the supply side (doctors and healthcare providers) of the health system. This helps to measure progress and enables data-driven adjustments to the programs where necessary.
In order to conduct thorough and scientific impact evaluations, the Health Insurance Fund contracts the Amsterdam Institute for Global Health and Development to research biomedical impact, and the Amsterdam Institute for International Development to measure socio-economic impact. These scientific research projects are often published in prestigious journals such as JAMA, British Medical Journal and The Lancet.
Also, a dedicated Learning & Analysis team within the PharmAccess Group, Health Insurance Fund's implementing partner, has been set up to share lessons learned with external stakeholders like donors, local partners, and the general public.
Click here to read the impact evaluation of the Kwara program.